Nasdaq
$12.78▼ 1.01%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $31.9MShares out 2.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
10- 10.13Regular26.10.13 23:406-KKey event#●●●
EUDA Health Holdings LtdBullish
EUDA Health Holdings will hold an Extraordinary General Meeting on October 30, 2026, to reclassify existing shares into Class A and Class B, implementing a dual-class share structure where Class B shares carry 50 votes per share. If approved, Tan Meng Dong and his affiliates will control approximately 89.5% of the total voting power while holding 14.6% of the outstanding shares, significantly consolidating their control over the company.…more
$12.78-1.01%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.13Pre-market26.10.13 19:306-KKey event
EUDA Health Holdings Ltd
EUDA Health Holdings Limited filed and finalized an amendment to its Memorandum and Articles of Association with the Registrar of Corporate Affairs in the British Virgin Islands on October 5, 2026. This report formally updates and provides the company's current governing documents.…more
$12.78-1.01%vs prev closeView filingShare - 9.29After-hours26.09.30 05:306-KKey event
EUDA Health Holdings Ltd
EUDA Health Holdings reported revenue of $3.47 million and a net loss of $796,950 for the first half of 2026. The company has experienced recurring operating losses since 2020, and management has determined that there is substantial doubt about its ability to continue as a going concern within one year.…more
$12.78-1.01%vs prev closeView filingShare
9 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 8.26Pre-market26.08.26 19:00#●●●
EUDA Health Subsidiary Melana International Wins SME100 Awards 2026
EUDA Health's subsidiary, Melana International, has been recognized as a winner of the SME100 Awards 2026 in Singapore. This award acknowledges the company's performance in property management, though it does not provide a direct financial impact on the stock.…more
$12.78-1.01%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 7.30Pre-market26.07.30 19:00
●●●●●●●● ●●●●● ●●●●●●
EUDA 헬스가 GO POSB 및 SIIT와 협력하여 암 치료 및 웰니스 분야의 차세대 세포 치료제 개발에 나섭니다. 이번 파트너십을 통해 세포 치료 기술의 상용화와 글로벌 시장 진출을 가속화할 계획입니다.…more
$12.78-1.01%vs prev close - 7.28Pre-market26.07.28 19:00
●●●●●●●● ●●●●● ●●●●●●
EUDA 헬스가 GO POSB 및 Shenzhen Inno와 차세대 iPSC 기반 항암 세포 치료제 개발 및 상용화를 위한 업무협약을 체결했습니다. 이번 협력은 회사의 혁신적인 헬스케어 제품 포트폴리오를 강화하고 아시아 시장 내 상업화 역량을 확대하기 위한 전략적 행보로 풀이됩니다.…more
$12.78-1.01%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report